Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Revenue

Intech Biopharm had revenue of 7.66M TWD in the quarter ending March 31, 2025, a decrease of -48.15%. This brings the company's revenue in the last twelve months to 32.67M, down -11.63% year-over-year. In the year 2024, Intech Biopharm had annual revenue of 39.78M with 53.90% growth.

• Revenue (ttm): 32.67M
• Revenue Growth: -11.63%
• P/S Ratio: 85.72
• Revenue / Employee: 362.98K
• Employees: 90
• Market Cap: 2.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	39.78M	13.93M	53.90%
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%
Dec 31, 2020	21.11M	4.42M	26.50%